Belarus vs Kazakhstan: Treatment success rate for patients treated for MDR-TB
Belarus
85.0%
in 2022
Kazakhstan
84.0%
in 2022
Belarus rank
35th
Kazakhstan rank
38th
Treatment success rate for patients treated for MDR-TB over time
- Belarus
- Kazakhstan
How they compare
Belarus currently reports 85.0% against 84.0% in Kazakhstan, a difference of 1.0%.
The two have swapped places 3 times across 14 shared years of data; in 2009 it was Kazakhstan ahead.
Belarus ranks 35th and Kazakhstan ranks 38th of 163 countries.
Across the 3 decades both report, Belarus averaged higher in 1 and Kazakhstan in 2.
Head to head by decade
| Decade | Belarus | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.0% | 73.0% | 33.0% | Kazakhstan |
| 2010s | 60.5% | 76.4% | 15.9% | Kazakhstan |
| 2020s | 82.0% | 80.7% | 1.3% | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Belarus or Kazakhstan?
- Belarus, at 85.0% against 84.0% in Kazakhstan as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Belarus and Kazakhstan?
- 1.0%, with Belarus ahead.
- How many years of comparable data are there for Belarus and Kazakhstan?
- 14 years are reported by both, from 2009 to 2022.
- How do Belarus and Kazakhstan rank globally for treatment success rate for patients treated for mdr-tb?
- Belarus ranks 35th and Kazakhstan ranks 38th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.